Policy
par
Canadian Drug Policy Coalition (CDPC)
Date de publication
2024
Géographie
Canada
Langue de la ressource
English
Texte disponible en version intégrale
Oui
Open Access / OK to Reproduce
Non
Évalué par des pairs
No
L’objectif
On June 1, 2024, Health Canada published a Regulatory Impact Analysis Statement for the proposed Controlled Substances Regulations (CSR) in the Canada Gazette, Part I. The regulatory proposal was subject to a 60-day public comment period ending on July 31, 2024. This submission was prepared in response by the Canadian Drug Policy Coalition (CDPC) on behalf of CDPC, the Harm Reduction Nurses Association, the HIV Legal Network and Pivot Legal Society.
Constatations/points à retenir
This submission follows seven general themes:
- Inadequate assessment of public health and human rights impacts
- The evolving nature and contemporary debate on UN Drug Control Conventions
- Lack of neutrality in language
- Disproportionate harmful impacts to equity-denied groups
- Inadequate framing of public safety
- Inadequate safeguards to ensure the rigor of information relied upon in Ministerial decision making
- Lack of flexibility to meet arising needs and promising practices
Mots clés
Advocacy
Equity
Policy/Regulatory
